FDA gives nod to RSV vaccine for people in their 50s
The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.
Jun 10, 2024
0
0